Application of oligomeric proantho cyanidins in preparing products resisting vascular dementia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology with low proanthocyanidins and proanthocyanidins, applied in the fields of food and beverages and medicine, can solve the problems such as procyanidins anti-vascular dementia products and procyanidins anti-vascular dementia products that have not yet been found, so as to reduce economic pressure and monitor burden, significant social benefits, and the effect of improving quality of life
Inactive Publication Date: 2009-09-16
ZHEJIANG XIAOSHAN HOSPITAL
View PDF0 Cites 9 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0108] However, through literature search, so far, no report on the appli...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
preparation example Construction
[0248] The preparation method of proanthocyanidins is a mature method, which has been published in various journals and patent documents, and will not be repeated in the present invention.
[0249] In the present invention, the specific implementation manners described above and the examples described below are for better illustrating the present invention, and are not used to limit the scope of the invention.
Embodiment 1
[0251] Embodiment 1, the preparation of proanthocyanidin tablet
[0252] prescription:
[0253] Proanthocyanidins 150g
[0254] Starch 80g
[0255] Lactose 20g
[0256] Sodium carboxymethyl starch 10g
[0257] Appropriate amount of starch slurry (7%)
[0258] Magnesium Stearate 1%
[0259] Made into 1000 pieces
[0260] Process:
[0261] Pass the proanthocyanidins through an 80-mesh sieve, mix with starch, lactose, and sodium carboxymethyl starch, and add starch slurry to make soft materials. Granulate through a 16-mesh sieve, dry below 60°C, granulate, add magnesium stearate, mix well, and compress into tablets. Can be made into 1000 tablets each containing 150mg proanthocyanidins.
Embodiment 2
[0262] Embodiment 2, the preparation of proanthocyanidin capsules
[0263] prescription:
[0264] Proanthocyanidins 150g
[0265] Starch 40g
[0266] Micronized silica gel 10g
[0267] Make 1000 capsules
[0268] Process:
[0269] The proanthocyanidins pass through a 80-mesh sieve, mix with the prescribed amount of starch and micropowder silica gel, and directly pack into capsules to make capsules containing 150mg of proanthocyanidins each.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to application of oligomeric proantho cyanidins in preparing products for preventing, diagnosing, detecting, protecting, treating and studying vascular dementia and directly related diseases thereof, in particular to new application in medicament and health-care products. Experiments prove that oligomeric proantho cyanidins can improve the study memory ability of a heart and brain ischemia-reperfusion mouse and a permanent bilateral common carotid arteries rat, inhibit lipid peroxidation in brains of the heart and brain ischemia-reperfusion mouse and the permanent bilateral common carotid arteries rat, and improve the superoxide dismutase enzyme activity of the heart and brain ischemia-reperfusion mouse and the permanent bilateral common carotid arteries rat. The oligomeric proantho cyanidins have strong action, clear effect, rich resource, simple preparation process, high yield, stable property and safe use, in particular one object with multiple functions and wide application range, and can play roles furthest. Disease rate of dementia rises gradually, after popularization, the application of oligomeric proantho cyanidins can generate significant social benefit and economic benefit in short time.
Description
technical field [0001] The invention relates to the technical fields of medicine, food and beverage, in particular to the use of traditional Chinese medicine extracts, and more specifically to the use of proanthocyanidins in the preparation of anti-vascular dementia products. Background technique [0002] (1) Research overview of proanthocyanidins [0003] 1 Overview [0004] Proanthocyanidins (Oligomeric Proantho Cyanidins, referred to as: OPCs or OPC), also known as concentrated genes (Pycnjogenols), is a bioflavonoid with a special molecular structure, is a high-efficiency cofactor, is currently recognized internationally, the most active It is the most effective natural antioxidant, scavenging free radicals and its anti-aging substances. It is generally a reddish-brown powder with a slight gas and astringent taste, soluble in water and most organic solvents. Typically grape seed extract or French maritime pine bark extract. [0005] Proanthocyanidins are a new type o...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more